Patents by Inventor Szilan Fodor

Szilan Fodor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • C-terminal anti-sclerostin antibody variants
    Patent number: 11858983
    Abstract: The invention generally relates to anti-sclerostin antibodies having C-terminal modifications, and compositions comprising such antibodies.
    Type: Grant
    Filed: September 23, 2022
    Date of Patent: January 2, 2024
    Assignee: AMGEN INC.
    Inventors: Zhe Huang, Jennitte LeAnn Stevens, Greg Flynn, Szilan Fodor, Mark Daris
  • C-TERMINAL ANTIBODY VARIANTS
    Publication number: 20230015713
    Abstract: The invention generally relates to anti-sclerostin antibodies having C-terminal modifications, and compositions comprising such antibodies.
    Type: Application
    Filed: September 23, 2022
    Publication date: January 19, 2023
    Inventors: Zhe Huang, Jennitte LeAnn Stevens, Greg Flynn, Szilan Fodor, Mark Daris
  • C-terminal antibody variants
    Patent number: 11466079
    Abstract: The invention generally relates to anti-sclerostin antibodies having C-terminal modifications, and compositions comprising such antibodies.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: October 11, 2022
    Assignee: AMGEN INC.
    Inventors: Zhe Huang, Jennitte LeAnn Stevens, Greg Flynn, Szilan Fodor, Mark Daris
  • C-TERMINAL ANTIBODY VARIANTS
    Publication number: 20210079082
    Abstract: The invention generally relates to anti-sclerostin antibodies having C-terminal modifications, and compositions comprising such antibodies.
    Type: Application
    Filed: March 29, 2019
    Publication date: March 18, 2021
    Inventors: Zhe Huang, Jennitte LeAnn Stevens, Greg Flynn, Szilan Fodor, Mark Daris